Open AccessObserved Cost and Variations in Short Term Cost‐Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke ( IMS ) III
Author(s) -
Simpson Kit N.,
Simpson Annie N.,
Mauldin Patrick D.,
Palesch Yuko Y.,
Yeatts Sharon D.,
Kleindorfer Dawn,
Tomsick Thomas A.,
Foster Lydia D.,
Demchuk Andrew M.,
Khatri Pooja,
Hill Michael D.,
Jauch Edward C.,
Jovin Tudor G.,
Yan Bernard,
Kummer Rüdiger,
Molina Carlos A.,
Goyal Mayank,
Schonewille Wouter J.,
Mazighi Mikael,
Engelter Stefan T.,
Anderson Craig,
Spilker Judith,
Carrozzella Janice,
Ryckborst Karla J.,
Janis L. Scott,
Broderick Joseph P.
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.004513
Subject(s) - medicine , stroke (engine) , modified rankin scale , tissue plasminogen activator , emergency medicine , quality of life (healthcare) , medical record , cost effectiveness , psychological intervention , quality adjusted life year , physical therapy , intensive care medicine , ischemic stroke , ischemia , mechanical engineering , risk analysis (engineering) , nursing , psychiatry , engineering
Examination of linked data on patient outcomes and cost of care may help identify areas where stroke care can be improved. We report on the association between variations in stroke severity, patient outcomes, cost, and treatment patterns observed over the acute hospital stay and through the 12-month follow-up for subjects receiving endovascular therapy compared to intravenous tissue plasminogen activator alone in the IMS (Interventional Management of Stroke) III Trial.